UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008298 |
|---|---|
| Receipt number | R000009444 |
| Scientific Title | Phase II trial of bi-weekly cetuximab plus mFOLFOX6 or cetuximab plus mFOLFIRI for unresectable advanced or recurrent KRAS wild type colorectal cancer (T-CORE1201) |
| Date of disclosure of the study information | 2012/06/29 |
| Last modified on | 2020/07/07 14:00:35 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/06/29 11:24:29 | ||
| 2 | Update | 2013/06/04 16:17:07 | Recruitment status |
|
| 3 | Update | 2016/01/05 09:29:43 | Email Last name of contact person Last name of contact person |
|
| 4 | Update | 2017/07/03 10:45:42 | Recruitment status |
|
| 5 | Update | 2017/07/03 10:48:13 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2019/01/04 08:56:43 | Last name of contact person Last name of contact person |
|
| 7 | Update | 2020/01/06 09:25:57 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Organization Organization Zip code Address TEL Homepage URL Organization Organization Address Address Tel |
|
| 8 | Update | 2020/01/06 09:27:42 | Number of participants that the trial has enrolled |
|
| 9 | Update | 2020/01/06 09:34:42 | Date of IRB Last follow-up date |
|
| 10 | Update | 2020/01/06 09:36:18 | Last follow-up date |
|
| 11 | Update | 2020/07/07 14:00:35 | Recruitment status |
